SiBone (NASDAQ:SIBN – Get Free Report) and Sintx Technologies (NASDAQ:SINT – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.
Volatility & Risk
SiBone has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500.
Insider and Institutional Ownership
98.1% of SiBone shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 4.0% of SiBone shares are held by insiders. Comparatively, 4.1% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| SiBone | -6.85% | -8.23% | -6.07% |
| Sintx Technologies | -848.20% | -354.44% | -115.37% |
Analyst Recommendations
This is a summary of current ratings and recommmendations for SiBone and Sintx Technologies, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SiBone | 1 | 0 | 6 | 0 | 2.71 |
| Sintx Technologies | 1 | 0 | 3 | 0 | 2.50 |
SiBone currently has a consensus target price of $24.17, suggesting a potential upside of 27.97%. Sintx Technologies has a consensus target price of $9.33, suggesting a potential upside of 526.40%. Given Sintx Technologies’ higher possible upside, analysts clearly believe Sintx Technologies is more favorable than SiBone.
Earnings & Valuation
This table compares SiBone and Sintx Technologies”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SiBone | $200.93 million | 4.17 | -$18.90 million | ($0.34) | -55.54 |
| Sintx Technologies | $1.02 million | 6.31 | -$10.36 million | ($4.91) | -0.30 |
Sintx Technologies has lower revenue, but higher earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
SiBone beats Sintx Technologies on 9 of the 14 factors compared between the two stocks.
About SiBone
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
About Sintx Technologies
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Receive News & Ratings for SiBone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SiBone and related companies with MarketBeat.com's FREE daily email newsletter.
